Purchases and Sales Made in Q3 2024 in Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR) during Q3 2024. The information is specifically focused on institutions that hold shares of ARROWHEAD PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
SELL
|
- |
-140K- 58.8% |
$2.71M - $4.13M
|
98.1K
$2.06M
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-167K- 7.22% |
$3.24M - $4.94M
|
2.15M
$45.2M
|
|
Nov 14, 2024
Q3 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-190K- 49.51% |
$3.68M - $5.61M
|
194K
$4.08M
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-210K- 11.54% |
$4.06M - $6.19M
|
1.61M
$33.8M
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-233K- 33.42% |
$4.51M - $6.88M
|
464K
$9.76M
|
|
Nov 14, 2024
Q3 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-519K- 70.3% |
$10M - $15.3M
|
219K
$4.62M
|
|
Nov 12, 2024
Q3 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-729K- 98.09% |
$14.1M - $21.5M
|
14.2K
$299K
|